The Phase 3 CagriSema program (REDEFINE 1, 2, REIMAGINE 2) capped cagrilintide at 2.4 mg per week
Patient reports are equally compelling
The deconvoluted spectrum sits alongside the chromatographic data in the COA, so the 39-residue chain, the C20 side chain, and the C-terminal serinamide can all be checked against expected values
Common early symptoms can include fatigue, joint pain, and skin rashes, which can easily be mistaken for other conditions, leading to frustration and prolonged suffering for patients
In four cancer types, the GLP-1 group was less likely to develop stage IV cancer: Lung cancer - 50% risk reduction Breast cancer - 43% risk reduction Liver cancer - 38% risk reduction Colorectal cancer - 31% risk reduction In the other three cancers - prostate, pancreatic and kidney - the GLP-1 group had fewer instances of stage IV disease, but the differences were not statistically significant